<VariationArchive VariationID="529908" VariationName="NM_004329.3(BMPR1A):c.44_47del (p.Leu15fs)" VariationType="Deletion" Accession="VCV000529908" Version="13" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-05-01" DateCreated="2013-04-04" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="525532" VariationID="529908">
      <GeneList>
        <Gene Symbol="BMPR1A" FullName="bone morphogenetic protein receptor type 1A" GeneID="657" HGNC_ID="HGNC:1076" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>10q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="86755763" stop="86932844" display_start="86755763" display_stop="86932844" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="88516395" stop="88684944" display_start="88516395" display_stop="88684944" Strand="+" />
          </Location>
          <OMIM>601299</OMIM>
          <Haploinsufficiency last_evaluated="2020-06-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BMPR1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-06-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BMPR1A">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_004329.3(BMPR1A):c.44_47del (p.Leu15fs)</Name>
      <CanonicalSPDI>NC_000010.11:86876059:TTTGTT:TT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>10q23.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="10" Accession="NC_000010.11" start="86876060" stop="86876063" display_start="86876060" display_stop="86876063" variantLength="4" positionVCF="86876059" referenceAlleleVCF="ATTTG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="10" Accession="NC_000010.10" start="88635817" stop="88635820" display_start="88635817" display_stop="88635820" variantLength="4" positionVCF="88635816" referenceAlleleVCF="ATTTG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>L15fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004329.2" sequenceAccession="NM_004329" sequenceVersion="2" change="c.44_47delTGTT">
            <Expression>NM_004329.2:c.44_47delTGTT</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.10" sequenceAccession="NC_000010" sequenceVersion="10" change="g.88635819_88635822del" Assembly="GRCh37">
            <Expression>NC_000010.10:g.88635819_88635822del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000010.11" sequenceAccession="NC_000010" sequenceVersion="11" change="g.86876062_86876065del" Assembly="GRCh38">
            <Expression>NC_000010.11:g.86876062_86876065del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009362.1" sequenceAccession="NG_009362" sequenceVersion="1" change="g.124424_124427del">
            <Expression>NG_009362.1:g.124424_124427del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004329.3" sequenceAccession="NM_004329" sequenceVersion="3" change="c.44_47del" MANESelect="true">
            <Expression>NM_004329.3:c.44_47del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004320.2" sequenceAccession="NP_004320" sequenceVersion="2" change="p.Leu15fs">
            <Expression>NP_004320.2:p.Leu15fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_298" sequenceAccession="LRG_298">
            <Expression>LRG_298:g.124424_124427del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_298t1" sequenceAccession="LRG_298t1">
            <Expression>LRG_298t1:c.44_47del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_298p1" sequenceAccession="LRG_298p1" change="p.Leu15fs">
            <Expression>LRG_298p1:p.Leu15fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658797453" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="601299.0001" DB="OMIM" />
        <XRef Type="rs" ID="1554886816" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004329.3(BMPR1A):c.44_47del (p.Leu15fs) AND Juvenile polyposis syndrome" Accession="RCV001376603" Version="7">
        <ClassifiedConditionList TraitSetID="65684">
          <ClassifiedCondition DB="MedGen" ID="C0345893">Juvenile polyposis syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-01-23" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004329.3(BMPR1A):c.44_47del (p.Leu15fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV002331136" Version="2">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-12-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004329.3(BMPR1A):c.44_47del (p.Leu15fs) AND Generalized juvenile polyposis/juvenile polyposis coli" Accession="RCV000635432" Version="5">
        <ClassifiedConditionList TraitSetID="2255">
          <ClassifiedCondition DB="MedGen" ID="C1868081">Generalized juvenile polyposis/juvenile polyposis coli</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-01-23" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2013-04-04" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11381269</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11536076</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12417513</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23399955</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2255" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2501" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Juvenile polyposis coli</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Generalized juvenile polyposis/juvenile polyposis coli</ElementValue>
                <XRef ID="MONDO:0008276" DB="MONDO" />
                <XRef ID="329971" DB="Orphanet" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17508" />
                <XRef ID="17508" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Juvenile polyposis syndrome (JPS) is characterized by predisposition to hamartomatous polyps in the gastrointestinal (GI) tract, specifically in the stomach, small intestine, colon, and rectum. The term "juvenile" refers to the type of polyp rather than to the age of onset of polyps. Most individuals with JPS have some polyps by age 20 years; some may have only four or five polyps over their lifetime, whereas others in the same family may have more than 100. If the polyps are left untreated, they may cause bleeding and anemia. Most juvenile polyps are benign; however, malignant transformation can occur. Risk for GI cancers ranges from 11% to 86%. Most of this increased risk is attributed to colon cancer, but cancers of the stomach, upper GI tract, and pancreas have also been reported. A combined syndrome of JPS and hereditary hemorrhagic telangiectasia (HHT) is present in most individuals with an SMAD4 pathogenic variant.</Attribute>
                <XRef ID="NBK1469" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301642</ID>
                <ID Source="BookShelf">NBK1469</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2004">
                <ID Source="PubMed">15604628</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACG, 2015">
                <ID Source="PubMed">25645574</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <XRef ID="329971" DB="Orphanet" />
              <XRef ID="C1868081" DB="MedGen" />
              <XRef ID="MONDO:0008276" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="65684" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="55407" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Juvenile polyposis syndrome</ElementValue>
                <XRef ID="Juvenile+polyposis+syndrome/3939" DB="Genetic Alliance" />
                <XRef ID="MONDO:0017380" DB="MONDO" />
                <XRef ID="9273005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polyposis juvenile intestinal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Polyposis familial of entire gastrointestinal tract</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">JPS</ElementValue>
                <XRef Type="MIM" ID="174900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PJI</ElementValue>
                <XRef Type="MIM" ID="174900" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">JIP</ElementValue>
                <XRef Type="MIM" ID="174900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Juvenile polyposis syndrome (JPS) is characterized by predisposition to hamartomatous polyps in the gastrointestinal (GI) tract, specifically in the stomach, small intestine, colon, and rectum. The term "juvenile" refers to the type of polyp rather than to the age of onset of polyps. Most individuals with JPS have some polyps by age 20 years; some may have only four or five polyps over their lifetime, whereas others in the same family may have more than 100. If the polyps are left untreated, they may cause bleeding and anemia. Most juvenile polyps are benign; however, malignant transformation can occur. Risk for GI cancers ranges from 11% to 86%. Most of this increased risk is attributed to colon cancer, but cancers of the stomach, upper GI tract, and pancreas have also been reported. A combined syndrome of JPS and hereditary hemorrhagic telangiectasia (HHT) is present in most individuals with an SMAD4 pathogenic variant.</Attribute>
                <XRef ID="NBK1469" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3065" />
                <XRef ID="3065" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301642</ID>
                <ID Source="BookShelf">NBK1469</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Genetics of Colorectal Cancer">
                <ID Source="PubMed">26389505</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="2929" DB="Orphanet" />
              <XRef ID="C0345893" DB="MedGen" />
              <XRef ID="MONDO:0017380" DB="MONDO" />
              <XRef Type="MIM" ID="174900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="28921" SubmissionDate="2010-10-18" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="601299.0001_JUVENILE POLYPOSIS SYNDROME" title="BMPR1A, 4-BP DEL, 44TGTT_JUVENILE POLYPOSIS SYNDROME" />
        <ClinVarAccession Accession="SCV000028921" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-06-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a kindred with juvenile polyposis (174900), Howe et al. (2001) found that affected members had a 4-bp deletion in exon 1 (44-47delTGTT) of the BMPR1A gene, resulting in a stop codon at nucleotides 104-106.</Attribute>
              <Citation>
                <ID Source="PubMed">11381269</ID>
              </Citation>
              <XRef DB="OMIM" ID="174900" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BMPR1A" />
          </GeneList>
          <Name>BMPR1A, 4-BP DEL, 44TGTT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, 44TGTT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="601299.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">JUVENILE POLYPOSIS SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2808723" SubmissionDate="2020-07-14" DateLastUpdated="2020-07-25" DateCreated="2020-07-25">
        <ClinVarSubmissionID localKey="NM_004329.2:c.44_47del|Juvenile polyposis syndrome" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001424375" DateUpdated="2020-07-25" DateCreated="2020-07-25" Type="SCV" Version="1" SubmitterName="Centogene AG  - the Rare Disease Company" OrgID="279559" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004329.2:c.44_47del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Juvenile polyposis syndrome</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>20200714_NPJ</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1466304" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="3162454|MedGen:C0345893" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000756845" DateUpdated="2024-02-14" DateCreated="2018-05-28" Type="SCV" Version="7" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11536076</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12417513</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11381269</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23399955</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in BMPR1A are known to be pathogenic (PMID: 11536076, 12417513). This variant has been reported in individuals affected with juvenile polyposis and colon cancer (PMID: 11381269) and has been reported to segregate with juvenile polyposis syndrome (JPS) in a single family (PMID: 23399955). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu15Serfs*20) in the BMPR1A gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BMPR1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000010.10:g.88635817_88635820del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0345893" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5118122" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a6117|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002629111" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-12-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11381269</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23399955</ID>
          </Citation>
          <Comment>The c.44_47delTGTT pathogenic mutation, located in coding exon 1 of the BMPR1A gene, results from a deletion of 4 nucleotides at nucleotide positions 44 to 47, causing a translational frameshift with a predicted alternate stop codon (p.L15Sfs*20). This alteration segregated with disease in 8 members of a juvenile polyposis family and was not seen in four unaffected family members (Howe JR et al. Nat. Genet., 2001 Jun;28:184-7). It was also seen in two patients with juvenile polyps who also had colon cancer ( (Ngeow J et al. Gastroenterology, 2013 Jun;144:1402-9, 1409.e1-5). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BMPR1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004329.2:c.44_47delTGTT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2808723" TraitType="Disease" MappingType="Name" MappingValue="Juvenile polyposis syndrome" MappingRef="Preferred">
        <MedGen CUI="C0345893" Name="Juvenile polyposis syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1466304" TraitType="Disease" MappingType="XRef" MappingValue="C0345893" MappingRef="MedGen">
        <MedGen CUI="C0345893" Name="Juvenile polyposis syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5118122" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="28921" TraitType="Disease" MappingType="Name" MappingValue="JUVENILE POLYPOSIS SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0345893" Name="Juvenile polyposis syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

